Developmental defects of enamel among Slovenian asthmatic children

T Samec1, J Jan1

  • 1Department of Cariology and Endodontics, Faculty of Medicine, University of Ljubljana, Slovenia.

Insights

Children with asthma have a higher prevalence of developmental defects of enamel (DDE) on permanent teeth. These dental issues are linked to asthma itself, not its treatment, necessitating specialized dental care for asthmatic children.

Area of Science:

  • Pediatric Dentistry
  • Respiratory Medicine
  • Dental Public Health

Background:

  • Asthma is a prevalent chronic respiratory condition in children.
  • Developmental defects of enamel (DDE) are a concern in pediatric dental health.
  • Previous research on asthma's impact on DDE prevalence is inconclusive.

Purpose of the Study:

  • To investigate the influence of childhood asthma on DDE prevalence.
  • To examine general and asthma-specific factors associated with DDE in asthmatic children.
  • To compare DDE prevalence between asthmatic children and healthy siblings.

Main Methods:

  • Cross-sectional study design involving 446 asthmatic children (aged 2-17) and 140 healthy siblings.
  • Utilized the DDE index to assess defects in primary and permanent teeth.
  • Collected data on confounding factors via parental questionnaires and medical records.

Main Results:

  • Asthmatic children exhibited a significantly higher prevalence of DDE on permanent teeth compared to healthy controls.
  • DDE prevalence was more strongly associated with asthma disease factors than with asthma medication use.
  • Identified a need for tailored dental care strategies for children with asthma.

Conclusions:

  • Childhood asthma is associated with an increased risk of developmental defects of enamel.
  • The underlying disease, rather than its treatment, appears to be the primary driver of DDE in asthmatic children.
  • Asthmatic children require specific dental management protocols to mitigate dental substance loss.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
451
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K